| Mrs Loyce Mae Pester, LPN | |
|
627 Grandview Ave, Pawhuska, OK 74056-4201 | |
| (918) 287-5645 | |
| (918) 287-5572 |
| Full Name | Mrs Loyce Mae Pester |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 627 Grandview Ave, Pawhuska, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568678969 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | L0043494 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Loyce Mae Pester, LPN Po Box 946, Pawhuska, OK 74056-0946 Ph: (918) 287-3776 | Mrs Loyce Mae Pester, LPN 627 Grandview Ave, Pawhuska, OK 74056-4201 Ph: (918) 287-5645 |
News Archive
With a weak alternating electrical current sent through electrodes attached to the scalp, UNC School of Medicine researchers successfully targeted a naturally occurring electrical pattern in a specific part of the brain and markedly improved depression symptoms in about 70 percent of participants in a clinical study.
Joslin researchers have gained new insights into how obesity and type 2 diabetes can create a stress response in the brain, especially in the hypothalamus (the brain region that regulates appetite and energy production), that may contribute to altering metabolism throughout the body. The findings are reported in the October issue of the Journal of Clinical Investigation.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.
› Verified 6 days ago
Karee Jo Molloy Kleier, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 627 Grandview Ave, Pawhuska, OK 74056 Phone: 918-287-5645 Fax: 918-287-5572 | |
Ms. Amber Nicole Jackson, L.P.N Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1800 Claremore Ave, Pawhuska, OK 74056 Phone: 918-724-6435 |